These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13227671)

  • 41. The distribution of radioactive chromium phosphate in tissue of rodents following intravenous injection.
    GABRIELI ER
    Acta Pathol Microbiol Scand; 1952; 31(2):195-204. PubMed ID: 14933094
    [No Abstract]   [Full Text] [Related]  

  • 42. Radioactivity in breast milk after intraperitoneal chromic phosphate for the treatment of early ovarian cancer.
    Carlson JA; Jose B; Sharma SC; Osborne RP
    Am J Obstet Gynecol; 1983 Dec; 147(7):840-1. PubMed ID: 6650612
    [No Abstract]   [Full Text] [Related]  

  • 43. Distribution of colloidal radioactive chromic phosphate after intracavitary administration.
    ROOT SW; TYOR MP; ANDREWS GA; KNISELEY RM
    Radiology; 1954 Aug; 63(2):251-9. PubMed ID: 13194879
    [No Abstract]   [Full Text] [Related]  

  • 44. Beta irradiation effects on reticulo-endothelial system following intravenous injection of radioactive chromium phosphate.
    GABRIELI ER; CUTLER JL
    Proc Soc Exp Biol Med; 1954 Dec; 87(3):661-5. PubMed ID: 13237337
    [No Abstract]   [Full Text] [Related]  

  • 45. Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma.
    Soper JT; Creasman WT; Clarke-Pearson DL; Sullivan DC; Vergadoro F; Johnston WW
    Am J Obstet Gynecol; 1985 Sep; 153(2):191-6. PubMed ID: 4037013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of prostatic carcinoma with radioactive colloidal chromic phosphate (p32); a preliminary report.
    RUSCHE C; JAFFE HL
    J Urol; 1954 Sep; 72(3):466-75. PubMed ID: 13202235
    [No Abstract]   [Full Text] [Related]  

  • 47. Further experiences in treatment of carcinoma of prostate with radioactive chromic phosphate and yttrium chloride.
    BULKLEY GJ; O'CONOR VJ; COOPER JA
    J Urol; 1957 Mar; 77(3):497-504. PubMed ID: 13417284
    [No Abstract]   [Full Text] [Related]  

  • 48. [Quantitative determination of the liver blood supply with use of a colloidal radioactive chromium phosphate].
    SCHMITT W; PIPPIG L; BECKER G
    Klin Wochenschr; 1961 Jul; 39():672-4. PubMed ID: 13748118
    [No Abstract]   [Full Text] [Related]  

  • 49. The treatment of prostatic carcinoma with radioactive colloidal chromic phosphate (P32); preliminary report.
    RUSCHE C; JAFFE HL
    Trans Am Assoc Genitourin Surg; 1953; 45():48-56. PubMed ID: 13169176
    [No Abstract]   [Full Text] [Related]  

  • 50. Prevention of malignant cell growth and spread by topical pretreatment with radioactive chromic phosphate.
    GOLDIE H; WALKER M; AGEE RE; KILDARE MW
    Proc Soc Exp Biol Med; 1960; 104():676-80. PubMed ID: 13706523
    [No Abstract]   [Full Text] [Related]  

  • 51. The simultaneous determination of red cell mass and plasma volume in man with radioactive sodium chromate and chromic chloride.
    GRAY SJ; FRANK H
    J Clin Invest; 1953 Oct; 32(10):1000-4. PubMed ID: 13096566
    [No Abstract]   [Full Text] [Related]  

  • 52. RECURRENT CYSTIC FORMATION IN CRANIOPHARYNGIOMA TREATED WITH RADIOACTIVE CHROMIC PHOSPHATE. CASE REPORT.
    OVERTON MC; SHEFFEL DD
    J Neurosurg; 1963 Aug; 20():707-10. PubMed ID: 14188843
    [No Abstract]   [Full Text] [Related]  

  • 53. [On the reaction kinetics of labelling normal human erythrocytes with Cr51-labelled sodium chromate and Cr51-labelled chromic chloride].
    MUNDSCHENK H; FISCHER J
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1962; 275():46-63. PubMed ID: 14477196
    [No Abstract]   [Full Text] [Related]  

  • 54. Radioactive colloidal chromic phosphate to control pleural effusion and ascites.
    JACOBS ML
    J Am Med Assoc; 1958 Feb; 166(6):597-9. PubMed ID: 13502033
    [No Abstract]   [Full Text] [Related]  

  • 55. Autoradiographic study of the distribution of radioactive particulate chromic phosphate in liver, spleen and lung of the mouse.
    ODEBLAD E; DOBSON EL; ODEBLAD AM; JONES HB
    Am J Physiol; 1955 Apr; 181(1):210-4. PubMed ID: 14376597
    [No Abstract]   [Full Text] [Related]  

  • 56. Radioactive chromic phosphate in treatment of urological tumors.
    MOORE V; GAMBLE D; LIBBY RL; GOODWIN WE
    Trans West Sect Am Urol Assoc; 1954; 21():128-34; discussion, 135-6. PubMed ID: 13216972
    [No Abstract]   [Full Text] [Related]  

  • 57. PREPARATION OF COLLOIDAL CHROMIC PHOSPHATE (P32) FOR MEDICAL USE.
    DELTURCO AM; PIETRA R
    Int J Appl Radiat Isot; 1963 Jul; 14():279-83. PubMed ID: 14046380
    [No Abstract]   [Full Text] [Related]  

  • 58. Intrapleural instillation of radioactive chromic phosphate in malignant pleural effusion.
    Nori D; Moorthy CR; Hilaris BS; Batata MA; Chu F; Martini N
    Indian J Cancer; 1981 Dec; 18(4):288-91. PubMed ID: 7341430
    [No Abstract]   [Full Text] [Related]  

  • 59. Citrate-buffered Cr-51-labelled chromic chloride--an extracellular radio-tracer with potential use in blood-brain barrier studies.
    Edström R
    Acta Psychiatr Scand; 1960; 35(1):27-33. PubMed ID: 13819379
    [No Abstract]   [Full Text] [Related]  

  • 60. Colloidalradioisotope therapy in leukemia with special reference to chromic phosphate P-32.
    HILL JM; SPEER RJ; MARSHALL GJ; LAJOUS JR
    Sang; 1955; 26(2):195-212. PubMed ID: 14396236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.